UPM-Kymmene Corporation:企業の戦略・SWOT・財務分析

◆英語タイトル:UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:MLINE7097382
◆発行会社(調査会社):MarketLine
◆発行日:2017年1月31日
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:包装・製紙
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥18,725見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD350 ⇒換算¥37,450見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD525 ⇒換算¥56,175見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

SummaryUPM-Kymmene Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Findings
- Detailed information on UPM-Kymmene Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting UPM-Kymmene Corporation in the form of a SWOT analysis
- An in-depth view of the business model of UPM-Kymmene Corporation including a breakdown and examination of key business segments
- Intelligence on UPM-Kymmene Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about UPM-Kymmene Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy
- Gain understanding of UPM-Kymmene Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess UPM-Kymmene Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on UPM-Kymmene Corporation’s business structure, strategy and prospects.

Key Highlights
UPM-Kymmene Corporation (UPM or ‘the company’) is engaged in manufacturing paper (printing and writing papers) and forest based products. The company primarily operates in Europe. It is headquartered in Helsinki, Finland.

【レポートの目次】

Company Snapshot
UPM-Kymmene Corporation: Company Overview
UPM-Kymmene Corporation: Overview and Key Facts
UPM-Kymmene Corporation: Overview
UPM-Kymmene Corporation: Key Facts
UPM-Kymmene Corporation: Key Employees
UPM-Kymmene Corporation: Key Employee Biographies
UPM-Kymmene Corporation: Major Products and Services
UPM-Kymmene Corporation: Company History
UPM-Kymmene Corporation: Management Statement
UPM-Kymmene Corporation: Locations and Subsidiaries
UPM-Kymmene Corporation: Key Competitors
UPM-Kymmene Corporation: Company Analysis
UPM-Kymmene Corporation: Business Description
UPM-Kymmene Corporation: SWOT Analysis
UPM-Kymmene Corporation: SWOT Overview
UPM-Kymmene Corporation: Strengths
UPM-Kymmene Corporation: Weaknesses
UPM-Kymmene Corporation: Opportunities
UPM-Kymmene Corporation: Threats
UPM-Kymmene Corporation: Corporate Financial Deals Activity
UPM-Kymmene Corporation: Financial Deals Overview
UPM-Kymmene Corporation: Targets and Partners
UPM-Kymmene Corporation: Top Deals 2013 – 2017YTD*
UPM-Kymmene Corporation: Partnership
UPM-Kymmene Corporation: Divestments
UPM-Kymmene Corporation: Recent Developments
UPM-Kymmene Corporation: News and Events Summary
UPM-Kymmene Corporation: Business Expansion
UPM-Kymmene Corporation: Corporate Governance
UPM-Kymmene Corporation: Financial Performance
UPM-Kymmene Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

Table 1: UPM-Kymmene Corporation: Key Facts
Table 2: UPM-Kymmene Corporation: Key Employees
Table 4: UPM-Kymmene Corporation: Key Competitors
Table 5: UPM-Kymmene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: UPM-Kymmene Corporation: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: UPM-Kymmene Corporation: Targets and Partners
Table 8: UPM-Kymmene Corporation: Top Deals 2013 - 2017YTD*
Table 9: UPM-Kymmene Corporation: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 10: UPM-Kymmene Corporation: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 11: UPM-Kymmene Corporation: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 12: UPM-Kymmene Corporation: Divestments by Geography (2013 - YTD*2017)
Table 13: UPM-Kymmene Corporation: News and Events Summary
Table 14: UPM-Kymmene Corporation: Business Expansion
Table 15: UPM-Kymmene Corporation: Corporate Governance
Table 16: UPM-Kymmene Corporation: Financial Performance
Table 17: UPM-Kymmene Corporation: Strategy and Operations

Figure 1: UPM-Kymmene Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: UPM-Kymmene Corporation: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Figure 3: UPM-Kymmene Corporation: Partnership Volume and Value Trend (2013 - YTD*2017)
Figure 4: UPM-Kymmene Corporation: Partnership Trend by Deal Type (2013 - YTD*2017)
Figure 5: UPM-Kymmene Corporation: Divestments Volume and Value Trend (2013 - YTD*2017)
Figure 6: UPM-Kymmene Corporation: Divestments by Geography (2013 - YTD*2017)

★海外企業調査レポート[UPM-Kymmene Corporation:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Instrumentation Laboratory Company:企業の製品パイプライン分析2018
    Summary Instrumentation Laboratory Company (IL), a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics (IVD) devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories …
  • Chronos Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Chronos Therapeutics Ltd (Chronos) is a research company that offers drug discovery and development services. The company offers research and development, drug discovery, lead optimization, preclinical efficacy, IND enabling, screening, pipeline development and clinical trial services. Its p …
  • SolarCity Corporation-エネルギー分野:企業M&A・提携分析
    Summary SolarCity Corporation (SolarCity), a subsidiary of Tesla, Inc., is a vertically integrated solar energy systems provider that designs, permits, finances, and installs the solar energy and storage systems,. The company also performs maintenance and monitoring services. It procures various com …
  • Abu Dhabi Future Energy Company PJSC:企業のM&A・提携動向(エネルギー分野)
    Summary Abu Dhabi Future Energy Company PJSC (Masdar) subsidiary of Mubadala Development Company is a renewable energy company which develops and commercializes renewable energy, clean, and sustainable technologies. It operates renewable power generation projects and invests in individual projects i …
  • Hanjin Shipping Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hanjin Shipping Co., Ltd. Merge …
  • Hartford Financial Services Group Inc.の企業概要及び財務/SWOT分析
    Hartford Financial Services Group Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus ann …
  • Medical & Biological Laboratories Co Ltd (4557)-医療機器分野:企業M&A・提携分析
    Summary Medical & Biological Laboratories Co Ltd (MBL) is a provider of clinical and basic laboratory diagnostics. The company’s products comprise research reagents, diagnostic reagents and companion diagnostics. It provides diagnostic reagents for therapeutic areas of allergy, antiphospholipid synd …
  • Delphi Genetics S.A.(製薬・医療分野):企業M&A動向
    Summary Delphi Genetics S.A. (Delphi Genetics) is a biotechnology company. The company develops new products and technologies for gene cloning and protein expression in bacteria. Its products include PCR cloning, staby cloning, protein expression, vector adaptation, reagents and media, in silico sol …
  • Grupo Financiero Galicia S.A.:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Grupo Financiero Galicia S.A." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric stri …
  • Exillon Energy Plc (EXI):石油・ガス:M&Aディール及び事業提携情報
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Nutex Nyrt. (NUTEX):企業の財務及び戦略的SWOT分析
    Summary Nutex Nyrt. (Nutex) formerly Humet Nyrt, is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products for physical and spiritual health care markets in domestic and international. The company offers health conserving, health improving, dietary supplement an …
  • Nolato AB (NOLA B):企業概要、財務及び戦略的SWOT分析
    Summary Nolato AB (Nolato) undertakes the development, manufacture and marketing of high-tech polymer products and components. It develops and manufactures products in plastic, silicone, thermoplastic elastomers (TPE) and rubber for companies within three areas, namely, medical, telecom and industri …
  • New Mauritius Hotels Ltd.の企業概要及び財務/SWOT分析
    New Mauritius Hotels Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quart …
  • Immuron Ltd (IMC)-製薬・医療分野:企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …
  • TCFC Finance Limited (532284):企業の財務及び戦略的SWOT分析
    Summary TCFC Finance Limited (TCFC Finance) is a non-banking finance company with core activities in the business of finance and investments and trading in equity shares, mutual funds and securities. The company is an investment company that operates its business through investments in equity, debt, …
  • The Siam Commercial Bank Public Company Limited (SCB):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "The Siam Commercial Bank Public Company Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible for …
  • Foundation Medicine Inc (FMI)-製薬・医療分野:企業M&A・提携分析
    Summary Foundation Medicine Inc (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd is a healthcare products provider that offers cancer care solutions. The company offers molecular information and cancer research programs. It offers clinical products which include FoundationOne for soli …
  • Wayport, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Wayport, Inc. Mergers and Acqui …
  • Lophius Biosciences GmbH:企業のM&A・提携動向(医療機器分野)
    Summary Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets innovative T cell-based diagnostic systems and research tools in the areas of infectious and autoimmune diseases, and transplantation. The company offers diagnostic kits, such as T-Track ImmunoScan assay …
  • Shenzhen Topray Solar Co.,Ltd. (002218):企業概要、財務及び戦略的SWOT分析
    Summary Shenzhen Topray Solar Co.,Ltd. (Topray Solar) is a solar energy company. The company manufactures and distributes solar energy products. It offers crystalline solar cells and modules, thin film solar modules, and solar stand alone systems to ultra clear PV glass. Topray Solar products includ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆